Human medicines European public assessment report (EPAR): Mimpara, cinacalcet, Date of authorisation: 22/10/2004, Revision: 27, Status: Withdrawn

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, European Medicines Agency, Amsterdam, the Netherlands, from 14 September 2026 to 18 September 2026

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, European Medicines Agency, Amsterdam, the Netherlands, from 12 October 2026 to 16 October 2026

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, European Medicines Agency, Amsterdam, the Netherlands, from 9 November 2026 to 13 November 2026

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, European Medicines Agency, Amsterdam, the Netherlands, from 7 December 2026 to 11 December 2026

HMPC meeting report on European Union herbal monographs, guidelines and other activities - 4-6 May 2026

Human medicines European public assessment report (EPAR): Dazparda, insulin aspart, Date of authorisation: 27/04/2026, Status: Authorised

Webinar on new approach methodologies (NAMs) in ecotoxicology: In silico approaches for fish acute toxicity, Online, European Medicines Agency, Amsterdam, the Netherlands, from 28 May 2026, 14:00 (CEST) to 28 May 2026, 15:30 (CEST)

EU tracks progress towards 2030 clinical trial targets

Clinical trials in human medicines